|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001480,
umls-concept:C0008976,
umls-concept:C0018017,
umls-concept:C0023824,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0360714,
umls-concept:C1142985,
umls-concept:C1280519,
umls-concept:C1524062,
umls-concept:C1546459
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-5-12
|
|
pubmed:abstractText |
To determine the extent of reduction in low-density lipoprotein cholesterol (LDL-C) level and improvement in National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) LDL-C goal attainment when ezetimibe was added to ongoing statin therapy in a diverse population of community-based patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Azetidines,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Monounsaturated,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles,
http://linkedlifedata.com/resource/pubmed/chemical/Lovastatin,
http://linkedlifedata.com/resource/pubmed/chemical/Pravastatin,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/ezetimibe,
http://linkedlifedata.com/resource/pubmed/chemical/fluvastatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0025-6196
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
587-95
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15887425-Aged,
pubmed-meshheading:15887425-Anticholesteremic Agents,
pubmed-meshheading:15887425-Azetidines,
pubmed-meshheading:15887425-Cholesterol, LDL,
pubmed-meshheading:15887425-Dose-Response Relationship, Drug,
pubmed-meshheading:15887425-Double-Blind Method,
pubmed-meshheading:15887425-Drug Therapy, Combination,
pubmed-meshheading:15887425-Fatty Acids, Monounsaturated,
pubmed-meshheading:15887425-Female,
pubmed-meshheading:15887425-Follow-Up Studies,
pubmed-meshheading:15887425-Heptanoic Acids,
pubmed-meshheading:15887425-Humans,
pubmed-meshheading:15887425-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:15887425-Hypercholesterolemia,
pubmed-meshheading:15887425-Indoles,
pubmed-meshheading:15887425-Lovastatin,
pubmed-meshheading:15887425-Male,
pubmed-meshheading:15887425-Middle Aged,
pubmed-meshheading:15887425-Nephelometry and Turbidimetry,
pubmed-meshheading:15887425-Practice Guidelines as Topic,
pubmed-meshheading:15887425-Pravastatin,
pubmed-meshheading:15887425-Pyrroles,
pubmed-meshheading:15887425-Retrospective Studies,
pubmed-meshheading:15887425-Risk Factors,
pubmed-meshheading:15887425-Simvastatin
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
|
|
pubmed:affiliation |
Department of Community & Preventive Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave, Box 644, Rochester, NY 14642, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
